We are live on ! Find out more
WGS icon

GeneDx Holdings

86 hedge funds and large institutions have $426M invested in GeneDx Holdings in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more funds holding in top 10

Funds holding in top 10: 16 (+5)

235% more capital invested

Capital invested by funds: $127M → $426M (+$299M)

233% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 12

118% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 11

85% more call options, than puts

Call options by funds: $3.58M | Put options by funds: $1.93M

48% more funds holding

Funds holding: 5886 (+28)

8.88% more ownership

Funds ownership: 53.39%62.27% (+8.9%)

Holders
86
Holders Change
+28
Holders Change %
+48.28%
% of All Funds
1.24%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.09%
New
40
Increased
24
Reduced
11
Closed
12
Calls
$3.58M
Puts
$1.93M
Net Calls
+$1.65M
Net Calls Change
+$1.83M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
1
Casdin Capital
New York
$92.2M +$7.39M +390,000 +12%
CM
2
Corvex Management
New York
$64.7M
OIM
3
Oracle Investment Management
Connecticut
$28.9M -$395K -20,839 -2%
Goldman Sachs
4
Goldman Sachs
New York
$27.5M -$1.39M -73,241 -7%
BlackRock
5
BlackRock
New York
$24.2M +$12.8M +677,644 +274%
Blackstone Inc
6
Blackstone Inc
New York
$21.8M
Vanguard Group
7
Vanguard Group
Pennsylvania
$20.6M +$1.53M +80,589 +11%
GS
8
Gagnon Securities
New York
$15M +$317K +16,734 +3%
DCM
9
Driehaus Capital Management
Illinois
$11.3M +$8.22M +433,635 New
Deutsche Bank
10
Deutsche Bank
Germany
$10.2M +$7.42M +391,485 +39,148,500%
Assenagon Asset Management
11
Assenagon Asset Management
Luxembourg
$9.57M +$6.94M +366,296 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$9.08M +$2.9M +152,851 +79%
Millennium Management
13
Millennium Management
New York
$8.14M +$3.89M +205,318 +194%
State Street
14
State Street
Massachusetts
$6.96M +$3.73M +197,037 +285%
GA
15
Gagnon Advisors
New York
$6.67M +$828K +43,666 +21%
Morgan Stanley
16
Morgan Stanley
New York
$6.21M -$10.5M -555,940 -70%
DSCM
17
Divisadero Street Capital Management
Florida
$5.89M +$4.27M +225,170 New
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$5.28M
BAM
19
Bosun Asset Management
Illinois
$4.38M +$3.17M +167,469 New
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$4.1M +$2.06M +108,864 +227%
Russell Investments Group
21
Russell Investments Group
United Kingdom
$3.79M +$2.75M +144,929 New
OAM
22
Oberweis Asset Management
Illinois
$3.19M +$2.31M +122,000 New
DC
23
Decheng Capital
California
$2.71M
Tudor Investment Corp
24
Tudor Investment Corp
Connecticut
$2.39M +$1.73M +91,487 New
Renaissance Technologies
25
Renaissance Technologies
New York
$2.36M +$1.71M +90,373 New

WGS Hedge Fund Activity: Q2 2024 in Review

86 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q2 2024, worth a combined $426M — up 235% from $127M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new WGS positions and 12 closed out — a net gain of 28 holders — while 24 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $12.8M. The largest seller was Soleus Capital Management, cutting an estimated $13.2M.

  • 86 institutional investors held GeneDx Holdings (WGS) as of Q2 2024, up from 58 in Q1 2024.
  • Funds reported $426M of GeneDx Holdings stock for Q2 2024, up 235% quarter-over-quarter.
  • 40 funds opened new GeneDx Holdings positions in Q2 2024 and 12 closed out, a net change of +28 holders.
  • The largest GeneDx Holdings buyer in Q2 2024 was BlackRock, an estimated $12.8M added.
  • The largest GeneDx Holdings seller in Q2 2024 was Soleus Capital Management, an estimated $13.2M sold.

Based on aggregated 13F filings for Q2 2024.